Chapter 14. Movement Disorders and Dopaminomimetic Stimulant Drugs

  1. Stewart A. Factor DO1,
  2. Anthony E. Lang MD2 and
  3. William J. Weiner MD3
  1. Anthony E. Munson,
  2. Juan Sanchez-Ramos and
  3. William J. Weiner

Published Online: 14 JAN 2008

DOI: 10.1002/9780470753217.ch14

Drug Induced Movement Disorders, Second Edition

Drug Induced Movement Disorders, Second Edition

How to Cite

Munson, A. E., Sanchez-Ramos, J. and Weiner, W. J. (2005) Movement Disorders and Dopaminomimetic Stimulant Drugs, in Drug Induced Movement Disorders, Second Edition (eds S. A. Factor, A. E. Lang and W. J. Weiner), Blackwell Publishing Inc., Malden, Massachusetts, USA. doi: 10.1002/9780470753217.ch14

Editor Information

  1. 1

    Movement Disorders Center, Department of Neurology, Emory University, Atlanta, USA

  2. 2

    Movement Disorders Clinic, Toronto Western Hospital, Toronto, Canada

  3. 3

    Department of Neurology, University of Maryland School of Medicine, Baltimore, USA

Publication History

  1. Published Online: 14 JAN 2008
  2. Published Print: 1 JAN 2005

ISBN Information

Print ISBN: 9781405126199

Online ISBN: 9780470753217

SEARCH

Keywords:

  • stimulant drugs;
  • dopaminergic activity;
  • methylphenidate;
  • pemoline;
  • cocaine

Summary

This chapter contains section titled:

  • Introduction

  • Amphetamine-induced movement disorders

  • Amphetamine, cocaine, methylphenidate, and pemoline in patients with a history of movement disorders

  • Conclusion